血清胃功能检测对萎缩性胃炎诊断及胃癌风险评估的研究进展

马英睿; 左赞; 郭强

血清胃功能检测对萎缩性胃炎诊断及胃癌风险评估的研究进展

马英睿^1,2,
左赞²,
郭强²

1. 大理大学临床医学院
2. 云南省第一人民医院消化内科

基金项目:

基金：国家自然科学基金资助项目 (81260323); 云南省科技创新人才计划项目-云南省第一人民医院消化病学研究省创新团队基金资助项目 (2012HC014);

计量
- 文章访问数: 2203
- HTML全文浏览量: 752
- PDF下载量: 345
- 被引次数: 0
出版历程
- 收稿日期: 2018-02-23

A Review of Advances Related to Serum Gastric Function Test in Diagnosis of Atrophic Gastritis and Risk Assessment of Gastric Cancer

Funds:

基金：国家自然科学基金资助项目 (81260323); 云南省科技创新人才计划项目-云南省第一人民医院消化病学研究省创新团队基金资助项目 (2012HC014);

摘要

摘要: 慢性萎缩性胃炎 (chronic atrophic gastritis, CAG) 作为公认的癌前疾病, 由于其症状不典型, 早期诊断率较低.大量研究表明, 通过血清胃功能指标测定, 包括蛋白酶原 (pepsinogen, PG) 和胃泌素17 (gastrin 17, G17) 水平的变化可反应胃粘膜功能及形态学状态, 而幽门螺杆菌 (H.pylori) 在粘膜萎缩及肠化过程中又起到促进作用, 间接影响上述指标的变化.就血清胃功能检测对萎缩性胃炎诊断及胃癌风险评估的研究进展作一综述.
- 胃蛋白酶原 /
- 胃泌素 /
- 幽门螺杆菌 /
- 萎缩性胃炎 /
- 胃癌
Abstract: As a recognized precancerous disease, the chronic atrophic gastritis (CAG) has a low diagnosis rate at an early stage due to its atypical symptoms. While massive studies have shown that changes in the serum gastric function parameters including pepsinogen (PG) and gastrin 17 (G17) levels which can be reflected by the functional and morphological status of the gastric mucosa, moreover, H. pylori plays a catalytic role in mucosal atrophy and intestinal metaplasia, indirectly affects the values of the above items. In this article, we discussd the progress in the diagnosis of atrophic gastritis and the risk assessment of gastric cancer based on serum gastric function tests.
- Pepsinogen /
- Gastrin /
- Helicobacter pylori /
- Atrophic gastritis /
- Gastric cancer

HTML全文

参考文献(48)

[1]李琼, 刘晏, 吴坚炯.慢性萎缩性胃炎的治疗进展[J].中医学报, 2013, 28 (1) :114-116.
[2]	[2]CORREA P, PIAZUELO M B.The gastric precancerous cascade[J].Journal of Digestive Diseases, 2012, 13 (1) :2-9.
[3]	[3]CHEN W, ZHENG R, BAADE P D, et al.Cancer statistics in China, 2015.[J].Ca A Cancer Journal for Clinicians, 2016, 66 (2) :115.
[4]上海市早期胃癌临床协作组.上海不同等级10个医疗机构早期胃癌的筛选结果比较[J].中华消化内镜杂志, 2007, 24 (1) :19-22.
[5]宋杰, 陈凤格, 赵伟, 等.胃癌的发病率现状与治疗研究进展[J].中国慢性病预防与控制, 2016, 24 (9) :704-707.
[6]	[6]HERRERO R, PARK J Y, FORMAN D.The fight against gastric cancer the IARC Working Group report[J].Best Practice&Research Clinical Gastroenterology, 2014, 28 (6) :1107-1114.
[7]	[7]PLUMMER M, DE M C, VIGNAT J, et al.Global burden of cancers attributable to infections in 2012:A synthetic analysis[J].Lancet Global Health, 2016, 4 (9) :e609.
[8]	[8]NAGY P, JOHANSSON S, MOLLOY-BLAND M.Systematic review of time trends in the prevalence of Helicobacter pylori, infection in China and the USA[J].Gut Pathogens, 2016, 8 (1) :8.
[9]王嫱, 褚南疆, 陈婷婷, 等.云南高原地区体检人群成人幽门螺杆菌感染的现状分析[J].昆明医科大学学报, 2015, 36 (10) :142-144.
[10]	[10]PLUMMER M, FRANCESCHI S, VIGNAT J, et al.Global burden of gastric cancer attributable to Helicobacter pylori[J].International Journal of Cancer Journal International, 2015, 136 (2) :487.
[11]	[11]ZHANG J, GUO J Z, XIAO H L, et al.Simultaneous detection of different serum pepsinogens and its primary application[J].World Journal of Gastroenterology, 2010, 16 (24) :3072.
[12]张玲霞, 庄坤, 张沥, 等.血清胃泌素-17胃蛋白酶原及幽门螺杆菌Ig-G抗体与萎缩性胃炎及胃癌的关系研究[J].检验医学与临床, 2014, 11 (8) :1076-1078.
[13]朱春平, 赵建业, 李兆申.血清胃泌素G-17在慢性萎缩性胃炎诊断中的研究进展[J].国际消化病杂志, 2015, 35 (1) :31-34.
[14]	[14]VAANANEN H, VAUHKONEN M, HELSKE T, et al.Non-endoscopic diagnosis of atrophic gastritis with a blood test.Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I:a multicentre study[J].European Journal of Gastroenterology&Hepatology, 2003, 15 (8) :885-891.
[15]	[15]SCHWANN T.Ueber das Wesen des Verdauungsprocesses[J].European Journal of Organic Chemistry, 2010, 20 (1) :28-34.
[16]	[16]KAGEYAMA T.Pepsinogens, progastricsins, and prochymosins:structure, function, evolution, and development[J].Cellular and Molecular Life Sciences:CMLS, 2002, 59 (2) :288-306.
[17]	[17]SAMLOFF I M.Pepsinogens, pepsins, and pepsin inhibitors.[J].Gastroenterology, 1971, 60 (4) :586.
[18]	[18]SAMLOFF I M, LIEBMAN W M.Cellular localization of the group II pepsinogens in human stomach and duodenum by immunofluorescence[J].Gastroenterology, 1973, 65 (1) :36-42.
[19]曹勤, 冉志华, 萧树东.血清胃蛋白酶原、胃泌素-17和幽门螺杆菌Ig G抗体筛查萎缩性胃炎和胃癌[J].胃肠病学, 2006, 11 (7) :388-394.
[20]张玲霞, 庄坤, 张沥, 等.血清胃蛋白酶原和胃泌素-17与萎缩性胃炎关系的研究[J].陕西医学杂志, 2014, 43 (3) :279-282.
[21]苟亚妮.胃蛋白酶原、幽门螺杆菌抗体联合胃泌素-17在胃癌高发区筛查萎缩性胃炎与胃癌的价值研究[D].兰州:兰州大学硕士论文, 2015.
[22]朱春平.基于胃癌危险因素和血清胃功能建立胃癌筛查策略的全国多中心研究[D].上海:第二军医大学硕士论文, 2017.
[23]朱春平, 赵建业, 申晓军, 等.血清胃泌素-17联合胃蛋白酶原检测对胃癌诊断价值的多中心临床研究[J].中华消化内镜杂志, 2017, 34 (1) :19-23.
[24]	[24]GOTODA T, ISHIKAWA H, OHNISHI H, et al.Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacterpylori and pepsinogens followed by gastrointestinal endoscopy[J].Gastric Cancer, 2014, 18 (3) :1-7.
[25] 中华医学会消化内镜学分会.中国早期胃癌筛查及内镜诊治共识意见 (2014年, 长沙) [J].中华消化杂志, 2014, 34 (7) :433-448.
[26]	[26]EDKINS J S.The chemical mechanism of gastric secretion.[J].The Journal of Physiology, 1906, 34 (1-2) :133.
[27]杜娟, 王秀琴.胃泌素的生物活性及其信号传导通路[J].解剖科学进展, 2003, 9 (4) :347-352.
[28]	[28]SAWADA M, DICKINSON C J.The G cell[J].Annual Review of Physiology, 1997, 59 (59) :273.
[29]刘德地, 张磊, 王亚雷, 等.血清胃蛋白酶原、促胃液素-17和幽门螺杆菌抗体对胃癌前状态筛查能力的评价[J].安徽医科大学学报, 2017, 52 (10) :1563-1567.
[30] 张玲霞, 庄坤, 张沥, 等.血清胃蛋白酶原和胃泌素-17与萎缩性胃炎关系的研究[J].陕西医学杂志, 2014, 9 (10) :279-282.
[31]朱春平, 赵建业, 钱维, 等.不同Hp感染状态下血清胃泌素-17对胃窦萎缩的诊断价值[J].胃肠病学, 2017, 22 (5) :282-286.
[32]高洪亮, 李宁, 张清禄.血清PGⅠ、PGⅡ及G-17检测在胃癌及萎缩性胃炎中的诊断价值分析[J].癌症进展, 2017, 15 (6) :654-656.
[33]	[33]SUN L, TU H, LIU J, et al.A comprehensive evaluation of fasting serum gastrin-17 as a predictor of diseased stomach in Chinese population[J].Scand J Gastroenterol, 2014, 49 (10) :1164-1172.
[34]陈莫耶, 徐倩, 孙丽萍, 等.血清胃泌素17水平与胃癌及癌前疾病的相关性研究[J].胃肠病学和肝病学杂志, 2015, 24 (2) :161-165.
[35]穆亚娟.胃黏膜癌变过程中血清胃泌素17的变化及根除Hp对其水平的影响[D].延安:延安大学硕士论文, 2017.
[36]	[36]MARSHALL B J, WARREN J R.Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration[J].Lancet, 1984, 1 (8390) :1311.
[37]	[37]FORMICHELLA L, ROMBERG L, MEYER H, et al.Validation of a novel immunoline assay for patient stratification according to virulence of the infecting helicobacter pylori strain and eradication status[J].Journal of Immunology Research, 2017, 2017 (12) :8394593.
[38]李凡, 韩梅.医学微生物学[M].北京:高等教育出版社, 2014:153.
[39]	[39]LIU S H, WONG O L, LEUNG W K.Helicobacter pylori associated gastric intestinal metaplasia:Treatment and surveillance[J].World Journal of Gastroenterology, 2016, 22 (3) :1311.
[40]	[40]MA J L, ZHANG L, BROWN L M, et al.Fifteen-year effects of helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality[J].Journal of the National Cancer Institute, 2012, 104 (6) :488-492.
[41]刘应玲, 陈思, 洪海鸥, 等.血清胃蛋白酶原、胃泌素17和幽门螺杆菌检测在胃癌前病变诊断中的价值[J].安徽医科大学学报, 2017, 52 (8) :1227-1231.
[42]	[42]ZAGARI R M, RABITTI S, GREENWOOD D C, et al.Systematic review with meta-analysis:Diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis.[J].Alimentary Pharmacology&Therapeutics, 2017, 46 (7) :657.
[43]	[43]ZHANG X, XUE L, XING L, et al.Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer:14-year follow up result in a rural Chinese community[J].International Journal of Cancer Journal International Du Cancer, 2012, 130 (7) :1614-1619.
[44] 朱春平.“中国早期胃癌筛查方案”国际研讨会成功举办[J].中华消化内镜杂志, 2015, 2 (2) :85.
[45]王佳.胃泌素17联合胃蛋白酶原血清学检测在胃癌筛查中的价值[D].太原:山西医科大学硕士论文, 2016.
[46]陈蕾, 顾云峰, 詹爱霞, 等.改良ABCD法在胃癌高危人群中的筛查价值[J].肿瘤, 2017, 37 (11) :1209-1217.
[47]	[47]TU H, SUN L, DONG X, et al.A serological biopsy using five stomach-specific circulating biomarkers for gastric cancer risk assessment:A multi-phase study[J].American Journal of Gastroenterology, 2017, 112 (5) :704.
[48]杜奕奇, 葵全才, 廖专, 等.中国早期胃癌筛查流程专家共识意见 (草案) (2017年, 上海) [J].胃肠病学, 2018, 23 (2) :92-97.

相关文章(20)

[1]	赵小青, 肖嘉欣, 林勇, 张剑锋, 王文辉, 张文杰. 不同毒力型的幽门螺杆菌对胃内微环境的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240221
[2]	唐嘉黛, 杨静, 宋红莉, 陈娇娇, 缪忠惠, 谢琳. 318例原发性胃癌转移及预后影响因素的相关分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230218
[3]	何汇琼, 张梦梅, 严映, 雷静, 杨亚英, 解开鹏. MSCT联合MRI成像对胃癌术前T分期的诊断价值, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230227
[4]	张梁, 王保全, 雷喜锋, 王旭, 柯阳, 张玮. M2巨噬细胞来源的外泌体miR-1246调控胃癌细胞的生长和侵袭, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230724
[5]	李小继, 杨雪芳, 刘骞, 和重祥, 杨勇, 李国荣. 丽江地区少数民族胃癌患者血清G-17、PG水平分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230429
[6]	马振桓, 李震, 周香林, 李国剑, 杨国凯, 万嘉, 杜玲娟, 杨镛. 碘-125粒子调控微小RNA-193b-5p抑制胃癌的增殖和侵袭, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220120
[7]	张莹, 高虹, 张翠香, 陈泽莹, 邹红群, 李丽琼, 杨巨品, 胡月新. 儿童幽门螺杆菌感染情况及其与缺铁性贫血的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220418
[8]	唐嘉黛, 谢琳, 宋红莉, 陈娇娇. 代谢综合征与胃癌发生发展的相关性研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211130
[9]	邹思思, 宋晓燕, 邓飞, 徐继宗. 胃癌及结直肠癌术后患者贫血的临床观察, 昆明医科大学学报.
[10]	程思根, 罗志刚, 刘德华, 杨姝. 幽门螺杆菌清除治疗中甲硝唑、克拉霉素、阿莫西林的耐药性, 昆明医科大学学报.
[11]	李瑶. 昆明地区口腔扁平苔癣与胃幽门螺杆菌的相关性, 昆明医科大学学报.
[12]	雷海锋. 血清Cyr61及CTGF水平对胃癌进展的诊疗意义, 昆明医科大学学报.
[13]	王丽昆. 三联、四联疗法及Boulardii酵母菌在幽门螺杆菌根除治疗中的疗效评估, 昆明医科大学学报.
[14]	王嫱. 云南高原地区体检人群成人幽门螺杆菌感染的现状分析, 昆明医科大学学报.
[15]	王丽昆. Boulardii酵母菌在根治幽门螺杆菌中的效果分析, 昆明医科大学学报.
[16]	赵波. 昆明地区儿童过敏性紫癜感染相关因素分析, 昆明医科大学学报.
[17]	王欢. 反复腹痛患儿及家庭成员中血浆胃泌素、P物质及血管活性肠肽变化的检测及意义, 昆明医科大学学报.
[18]	宋吉. Cyclin D1、P16及CDK4基因与胃癌相关性的研究进展, 昆明医科大学学报.
[19]	. XAGE-1基因在胃癌组织中的表达及其临床意义分析, 昆明医科大学学报.
[20]	曹佳. 反复腹痛患儿及家庭成员中幽门螺杆菌感染和外周血淋巴细胞/单核细胞HLA-DR的表达水平, 昆明医科大学学报.